Stay updated on Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.5.3 was added and Revision: v3.5.2 was removed, reflecting a small update to the page’s version history. It indicates an administrative update rather than a substantive change to study details.
    Difference
    0.1%
    Check dated 2026-04-30T18:53:16.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision identifiers updated: added v3.5.2 and removed v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:16:41.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T21:09:32.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T18:29:35.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added site revision indicator 'Revision: v3.4.2' and removed the prior 'lapse in government funding' notice and the 'Revision: v3.4.1' notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:23:11.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and NIH Clinical Center operations, and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:34:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial page.